Suppr超能文献

吸食大麻对健康的大麻吸食者和感染艾滋病毒的大麻吸食者的影响。

Effects of smoked marijuana in healthy and HIV + marijuana smokers.

作者信息

Haney Margaret

机构信息

New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York 10032, USA.

出版信息

J Clin Pharmacol. 2002 Nov;42(S1):34S-40S. doi: 10.1002/j.1552-4604.2002.tb06001.x.

Abstract

This article presents data from two avenues of marijuana research. First, the author shows that daily marijuana smoking in healthy individuals produces dependence, as demonstrated by withdrawal symptoms such as increased irritability and depression and decreased food intake. In addition, two antidepressant medications were evaluated to assess their potential effectiveness in the treatment of marijuana withdrawal symptoms: (1) sustained-release bupropion (0, 300 mg/day) and (2) nefazodone (0, 450 mg/day). Research participants were regular marijuana smokers who lived in a residential laboratory in groups of two to four. While inpatients, participants smoked active marijuana (2.8%-3.1% THC) repeatedly for 4 days, followed by 8 to 12 days of placebo marijuana (0.0% THC). Results show that during marijuana abstinence, (1) bupropion increased ratings of irritability, depression, and stomach pain and decreased food intake and sleep quality compared to placebo maintenance, and (2) nefazodone decreased anxiety during marijuana withdrawal but did not alter ratings of irritability and misery. Thus, neither medication showed promise as potential treatments for symptoms of marijuana withdrawal. The second avenue of research focused on the effect of cannabinoids in individuals with muscle mass loss, an indicator of wasting in HIV illness. Given that there are little scientific data contributing to the debates concerning medical marijuana, this study directly compared the effects of oral delta9-THC (0, 10, 20, 30 mg PO) to smoked marijuana (0.0%, 1.8%, 2.8%, 3.9% THC) in HIV + marijuana smokers with muscle mass loss (< 90% body cell mass/height). Multiple dimensions of human behavior were measured, including food intake, mood, and cognitive performance. Drugs were administered using a within-subject, double-blind, staggered, double-dummy design. Participants were free to self-select from a variety of foods throughout most of the session. Preliminary data (n = 9) suggest that oral THC was more effective at increasing food intake, but the volunteers "liked" the effects of smoked marijuana more than the effects of oral THC.

摘要

本文介绍了大麻研究的两条途径所获得的数据。首先,作者表明,健康个体每日吸食大麻会产生依赖性,如易怒、抑郁加剧以及食物摄入量减少等戒断症状就证明了这一点。此外,对两种抗抑郁药物进行了评估,以评估它们在治疗大麻戒断症状方面的潜在效果:(1)缓释安非他酮(0、300毫克/天)和(2)奈法唑酮(0、450毫克/天)。研究参与者为经常吸食大麻者,他们以两到四人一组的形式住在一个住院实验室里。住院期间,参与者反复吸食活性大麻(四氢大麻酚含量为2.8%-3.1%),持续4天,随后吸食8至12天的安慰剂大麻(四氢大麻酚含量为0.0%)。结果显示,在戒除大麻期间,(1)与服用安慰剂相比,安非他酮会使易怒、抑郁和胃痛的评分增加,食物摄入量和睡眠质量降低;(2)奈法唑酮在大麻戒断期间能减轻焦虑,但不会改变易怒和痛苦的评分。因此,这两种药物都未显示出有望成为治疗大麻戒断症状的潜在疗法。研究的第二条途径聚焦于大麻素对肌肉量减少个体的影响,肌肉量减少是艾滋病患者消瘦的一个指标。鉴于几乎没有科学数据为有关医用大麻的争论提供依据,本研究直接比较了口服Δ9-四氢大麻酚(0、10、20、30毫克口服)与吸食大麻(四氢大麻酚含量为0.0%、1.8%、2.8%、3.9%)对伴有肌肉量减少(体细胞质量/身高<90%)的艾滋病病毒阳性大麻吸食者的影响。对人类行为的多个维度进行了测量,包括食物摄入量、情绪和认知表现。药物采用受试者内、双盲、交错、双模拟设计给药。在大部分实验过程中,参与者可以自由从各种食物中自行选择。初步数据(n = 9)表明,口服四氢大麻酚在增加食物摄入量方面更有效,但志愿者对吸食大麻效果的“喜爱”超过口服四氢大麻酚的效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验